MONMOUTH JUNCTION, N.J., May 30, 2019 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today it was selected by the National Institutes of Health (NIH) as one of Small Business Innovation Research (SBIR) awardees to showcase its technology at the BIO 2019 International Convention held June 3 – 6 in Philadelphia, PA. Kira Sheinerman, PhD, Chief Executive Officer, will be presenting on Monday, June 3, at 3:15 PM EST in Theater 4 of the Philadelphia Convention Center.